ABU DHABI - The Abu Dhabi Stem Cells Center (ADSCC), in collaboration with Sheikh Khalifa Medical City, has treated its first Emirati patient through the Abu Dhabi Bone Marrow Transplant program (AD-BMT). The transplant was performed in Abu Dhabi, and the patient is recovering well at home.The AD-BMT program was established by ADSCC in August 2020 and has been treating patients since its inception in collaboration with Sheikh Khalifa Medical City. The AD-BMT program relies on stem cell therapy to treat patients with hematological and oncological illnesses, including bone marrow transplantation, which is an established stem cell-based treatment for a number of blood malignancies. These include multiple myeloma, plasma cell leukemia, large diffuse B-cell lymphoma, and Hodgkin lymphoma, as well as autoimmune diseases and benign hematological conditions such as thalassemia, among others.In less than a year, eight patients with different types of blood malignancies have been treated. AbdelRahman Al Jaberi, the eighth patient in question, said: “I wasn’t aware that...read more...